Martin Shkreli has argued in court that Wu-Tang Clan members should have their say in the legal case he’s involved in over a one-off album.
Martin Shkreli argued members of the Wu-Tang Clan should be included in a court battle he’s facing over the rap group’s ...
Investing.com -- Martin Shkreli, a controversial figure in the investment world, has recommended short selling quantum computing stocks. This comes in the wake of a significant rally in these stocks ...
Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Tianjin ...
Taylor Goldsmith is keenly aware that the Dawes who released the album Oh Brother last fall are far different from the band that dropped their breakout LP, Nothing Is Wrong, in 2011. Not only has ...
Pop star Lily Allen has declared she wants to get her "head straight" and release a new album by the end of the year. Trump orders all federal DEI employees placed on paid leave starting Wednesday ...
The artificial intelligence (AI) trade is expanding beyond semiconductors and into infrastructure, data centers, software, inference capabilities, and more. Global X assistant vice president and ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
What Happened: Shkreli, popularly known as “Pharma Bro,” took to X to vent his thoughts on MicroStrategy’s ongoing downturn, which has resulted in the stock plummetting more than 15% in a week.
One alleged that he is “about to drop the greatest 57 song album.” Netizens reacted as Wallen released a surprise single (Image via Instagram / @outlawcountrysongs) Others also said similar ...
Grab your popcorn and charge your group chats because 2025 is set to be a year where we practically live in cinemas. After a few unpredictable seasons in the movie industry, the upcoming year is ...
WU-CART-007 is under clinical development by Wugen and currently ... algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center. Give your ...